Uniqure N.V. current report, 14 September 2017

Business Context and Reporting Period

This Form 8-K filing by uniQure N.V. reports on the results of an Extraordinary General Meeting of Shareholders (EGM) held on September 14, 2017. The company is incorporated in The Netherlands and is classified as an emerging growth company.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and shareholder voting outcomes.

Material Changes and Voting Results

All resolutions proposed at the EGM were passed. The total number of ordinary shares eligible to vote was 25,629,099, with 13,026,542 shares voted. The specific outcomes were:

  • Agenda Item 2: Appointment of Dr. Springhorn as a non-executive director.
    • Votes in favor: 12,815,265
    • Votes against: 104,232
    • Abstentions: 107,045
  • Agenda Item 3: Appointment of Mr. Balachandran as a non-executive director.
    • Votes in favor: 12,878,314
    • Votes against: 41,170
    • Abstentions: 107,058

Both directors were appointed for terms ending at the 2020 Annual General Meeting.

Guidance, Outlook, and Risks

The filing text does not provide a clear value for financial guidance, management commentary on future outlook, specific risks, contingencies, or unusual items. The document serves solely to disclose the completion of the shareholder vote.

Investor Verification Checklist

  • Verify the official appointment of Dr. Springhorn and Mr. Balachandran to the Board of Directors.
  • Confirm the term end date for the new directors (2020 AGM).
  • Review the company's proxy statement for detailed biographies and rationale regarding the director appointments.
  • Note that this filing contains no financial performance data; refer to the most recent 10-K or 10-Q for financial metrics.